(Q46906701)

26 December 2017

title

Breast cancer in limited-resource countries: treatment and allocation of resources (English)

1 reference

26 December 2017

author name string

Alexandru Eniu

1

1 reference

26 December 2017

Robert W Carlson

2

1 reference

26 December 2017

Zeba Aziz

3

1 reference

26 December 2017

José Bines

4

1 reference

26 December 2017

Gabriel N Hortobágyi

5

1 reference

26 December 2017

Nuran Senel Bese

6

1 reference

26 December 2017

Richard R Love

7

1 reference

26 December 2017

Bhadrasain Vikram

8

1 reference

26 December 2017

Arun Kurkure

9

1 reference

26 December 2017

Benjamin O Anderson

10

1 reference

26 December 2017

Global Summit Treatment and Allocation of Resources Panel

11

1 reference

26 December 2017

publication date

1 January 2006

1 reference

26 December 2017

published in

The Breast Journal

1 reference

26 December 2017

volume

12 Suppl 1

1 reference

26 December 2017

page(s)

S38-53

1 reference

26 December 2017

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Treatment of breast cancer in countries with limited resources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Overview of Breast Health Care Guidelines for Countries with Limited Resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Revision of the American Joint Committee on Cancer staging system for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Immediate breast reconstruction after mastectomy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Aromatase inhibitors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Scheduling of fluorouracil: a forget-me-not in the jungle of doublets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Locally advanced breast cancer: is surgery necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00202.X

10.1111/J.1075-122X.2006.00202.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017